These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

410 related articles for article (PubMed ID: 25880030)

  • 1. HPV E6/E7 mRNA versus HPV DNA biomarker in cervical cancer screening of a group of Macedonian women.
    Duvlis S; Popovska-Jankovic K; Arsova ZS; Memeti S; Popeska Z; Plaseska-Karanfilska D
    J Med Virol; 2015 Sep; 87(9):1578-86. PubMed ID: 25880030
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical Value of Human Papillomavirus E6/E7 mRNA Detection in Screening for Cervical Cancer in Women Positive for Human Papillomavirus DNA or.
    Han L; Husaiyin S; Zhao F; Rezhake R; Niyazi M
    Clin Lab; 2018 Sep; 64(9):1363-1371. PubMed ID: 30274003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic Performance of HPV E6/E7 mRNA and HPV DNA Assays for the Detection and Screening of Oncogenic Human Papillomavirus Infection among Woman with Cervical Lesions in China.
    Wang HY; Lee D; Park S; Kim G; Kim S; Han L; Yubo R; Li Y; Park KH; Lee H
    Asian Pac J Cancer Prev; 2015; 16(17):7633-40. PubMed ID: 26625774
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-risk human papillomavirus E6/E7 mRNA and L1 DNA as markers of residual/recurrent cervical intraepithelial neoplasia.
    Persson M; Brismar Wendel S; Ljungblad L; Johansson B; Weiderpass E; Andersson S
    Oncol Rep; 2012 Jul; 28(1):346-52. PubMed ID: 22484610
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human Papillomavirus E6/E7 oncogene transcripts as biomarkers for the early detection of cervical cancer.
    Gupta SM; Warke H; Chaudhari H; Mavani P; Katke RD; Kerkar SC; Mania-Pramanik J
    J Med Virol; 2022 Jul; 94(7):3368-3375. PubMed ID: 35257379
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic performance of the E6/E7 mRNA-based Optimygene HR-HPV RT-qDx assay for cervical cancer screening.
    Wang HY; Kim H; Park KH
    Int J Infect Dis; 2019 Jan; 78():22-30. PubMed ID: 30248464
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [HPV E6 and E7 mRNA combined with HPV 16 and 18 or 45 genotyping testing as a means of cervical cancer opportunistic screening].
    Wang JJ; Dong J; Deng ZX; Wang PF; Zhang XX; Du Y
    Zhonghua Fu Chan Ke Za Zhi; 2019 May; 54(5):301-306. PubMed ID: 31154710
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparison Between HPV DNA Testing and HPV E6/E7 MRNA Testing in Women with Squamous Cell Abnormalities of the Uterine Cervix.
    Dabeski D; Duvlis S; Basheska N; Antovska V; Stojovski M; Trajanova M; Dimitrov G; Dabeski A; Gureva-Gjorgievska N
    Pril (Makedon Akad Nauk Umet Odd Med Nauki); 2019 May; 40(1):51-58. PubMed ID: 31152639
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human papillomavirus (HPV) E6/E7 mRNA as a triage test after detection of HPV 16 and HPV 18 DNA.
    Perez Castro S; Iñarrea Fernández A; Lamas González MJ; Sarán Diez MT; Cid Lama A; Alvarez Martín MJ; Pato Mosquera M; López-Miragaya I; Estévez N; Torres Piñón J; Oña Navarro M
    J Med Virol; 2013 Jun; 85(6):1063-8. PubMed ID: 23588733
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical performance of human papillomavirus E6 and E7 mRNA testing for high-grade lesions of the cervix.
    Cattani P; Zannoni GF; Ricci C; D'Onghia S; Trivellizzi IN; Di Franco A; Vellone VG; Durante M; Fadda G; Scambia G; Capelli G; De Vincenzo R
    J Clin Microbiol; 2009 Dec; 47(12):3895-901. PubMed ID: 19828739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantification of intracellular HPV E6/E7 mRNA expression increases the specificity and positive predictive value of cervical cancer screening compared to HPV DNA.
    Coquillard G; Palao B; Patterson BK
    Gynecol Oncol; 2011 Jan; 120(1):89-93. PubMed ID: 20950847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Performance of p16/Ki67 immunostaining, HPV E6/E7 mRNA testing, and HPV DNA assay to detect high-grade cervical dysplasia in women with ASCUS.
    Zhu Y; Ren C; Yang L; Zhang X; Liu L; Wang Z
    BMC Cancer; 2019 Mar; 19(1):271. PubMed ID: 30917784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the performance of the NucliSENS EasyQ HPV E6/E7 mRNA assay and HPV DNA chip for testing squamous cell lesions of the uterine cervix.
    Munkhdelger J; Choi Y; Lee D; Kim S; Kim G; Park S; Choi E; Jin H; Jeon BY; Lee H; Park KH
    Diagn Microbiol Infect Dis; 2014 Aug; 79(4):422-7. PubMed ID: 24856365
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human papillomavirus oncogene mRNA testing for the detection of anal dysplasia in HIV-positive men who have sex with men.
    Silling S; Kreuter A; Hellmich M; Swoboda J; Pfister H; Wieland U
    J Clin Virol; 2012 Apr; 53(4):325-31. PubMed ID: 22261122
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sensitivity, specificity, and clinical value of human papillomavirus (HPV) E6/E7 mRNA assay as a triage test for cervical cytology and HPV DNA test.
    Benevolo M; Vocaturo A; Caraceni D; French D; Rosini S; Zappacosta R; Terrenato I; Ciccocioppo L; Frega A; Giorgi Rossi P
    J Clin Microbiol; 2011 Jul; 49(7):2643-50. PubMed ID: 21525231
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictive testing of early cervical pre-cancer by detecting human papillomavirus E6/E7 mRNA in cervical cytologies up to high-grade squamous intraepithelial lesions: diagnostic and prognostic implications.
    Varnai AD; Bollmann M; Bankfalvi A; Speich N; Schmitt C; Griefingholt H; Kovács K; Klozoris C; Bollmann R
    Oncol Rep; 2008 Feb; 19(2):457-65. PubMed ID: 18202795
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human papillomavirus mRNA testing for the detection of anal high-grade squamous intraepithelial lesions in men who have sex with men infected with HIV.
    Sendagorta E; Romero MP; Bernardino JI; Beato MJ; Alvarez-Gallego M; Herranz P
    J Med Virol; 2015 Aug; 87(8):1397-403. PubMed ID: 25940055
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparing triage algorithms using HPV DNA genotyping, HPV E7 mRNA detection and cytology in high-risk HPV DNA-positive women.
    Luttmer R; Berkhof J; Dijkstra MG; van Kemenade FJ; Snijders PJ; Heideman DA; Meijer CJ
    J Clin Virol; 2015 Jun; 67():59-66. PubMed ID: 25959161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p16/ki67 and E6/E7 mRNA Accuracy and Prognostic Value in Triaging HPV DNA-Positive Women.
    Giorgi Rossi P; Carozzi F; Ronco G; Allia E; Bisanzi S; Gillio-Tos A; De Marco L; Rizzolo R; Gustinucci D; Del Mistro A; Frayle H; Confortini M; Iossa A; Cesarini E; Bulletti S; Passamonti B; Gori S; Toniolo L; Barca A; Bonvicini L; Mancuso P; Venturelli F; Benevolo M;
    J Natl Cancer Inst; 2021 Mar; 113(3):292-300. PubMed ID: 32745170
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The clinical value of HPV E6/E7 and STAT3 mRNA detection in cervical cancer screening.
    Fan Y; Shen Z
    Pathol Res Pract; 2018 May; 214(5):767-775. PubMed ID: 29655523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.